The bidirectional relationship between Alzheimer's disease (AD) and epilepsy: A Mendelian randomization study

Brain Behav. 2023 Nov;13(11):e3221. doi: 10.1002/brb3.3221. Epub 2023 Sep 4.

Abstract

Background: There is a complex, bidirectional relationship between Alzheimer's disease (AD) and epilepsy. However, the causality of this association is unclear, as confounders play a role in this association.

Methods: We conducted a Mendelian randomization (MR) study to clarify the causal relationship and direction of epilepsy on AD risk. We used publicly available summary statistics to obtain all genetic datasets for the MR analyses. AD and AD-by-proxy and late-onset AD (LOAD) cohorts were included in our study. The epilepsy cohort comprised all epilepsy, generalized epilepsy, focal epilepsy, and its subtypes, as well as some epilepsy syndromes. Next, we conducted validation using another AD cohort.

Results: Two correlations between AD and epilepsy using the inverse variance-weighted (IVW) method are as follows: LOAD and focal epilepsy (ORIVW = 1.079, pIVW = .013), focal epilepsy-documented hippocampal sclerosis (HS) and AD (ORIVW = 1.152, pIVW = .017). The causal relationship between epilepsy-documented HS and AD has been validated (ORIVW = 3.994, pIVW = .027).

Conclusions: Our MR study provides evidence for a causal relationship between focal epilepsy-documented HS and AD.

Keywords: Alzheimer's disease; Alzheimer's disease (late onset) (load); Mendelian randomization; epilepsy; focal epilepsy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / genetics
  • Epilepsies, Partial*
  • Epilepsy* / epidemiology
  • Epilepsy* / genetics
  • Epilepsy, Generalized*
  • Genome-Wide Association Study
  • Hippocampal Sclerosis*
  • Humans
  • Mendelian Randomization Analysis